DK72284A - Farmaceutisk middel med metabolisk og energetisk virkning til anvendelse i kardial- og vaskulaerterapi - Google Patents

Farmaceutisk middel med metabolisk og energetisk virkning til anvendelse i kardial- og vaskulaerterapi Download PDF

Info

Publication number
DK72284A
DK72284A DK72284A DK72284A DK72284A DK 72284 A DK72284 A DK 72284A DK 72284 A DK72284 A DK 72284A DK 72284 A DK72284 A DK 72284A DK 72284 A DK72284 A DK 72284A
Authority
DK
Denmark
Prior art keywords
cardial
metabolic
pharmaceutical agent
energy effect
vascular therapy
Prior art date
Application number
DK72284A
Other languages
English (en)
Other versions
DK165167B (da
DK72284D0 (da
DK165167C (da
Inventor
Alberto Bertelli
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of DK72284D0 publication Critical patent/DK72284D0/da
Publication of DK72284A publication Critical patent/DK72284A/da
Publication of DK165167B publication Critical patent/DK165167B/da
Application granted granted Critical
Publication of DK165167C publication Critical patent/DK165167C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DK072284A 1983-02-16 1984-02-16 Farmaceutisk middel med metabolisk og energetisk virkning indeholdende coenzym q10 og carnitin eller acetylcarnitin DK165167C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH858/83A CH655005A5 (it) 1983-02-16 1983-02-16 Composizione farmaceutica ad azione metabolica ed energetica utilizzabile in terapia cardiaca e vascolare.
CH85883 1983-02-16

Publications (4)

Publication Number Publication Date
DK72284D0 DK72284D0 (da) 1984-02-16
DK72284A true DK72284A (da) 1984-08-17
DK165167B DK165167B (da) 1992-10-19
DK165167C DK165167C (da) 1993-03-01

Family

ID=4196830

Family Applications (1)

Application Number Title Priority Date Filing Date
DK072284A DK165167C (da) 1983-02-16 1984-02-16 Farmaceutisk middel med metabolisk og energetisk virkning indeholdende coenzym q10 og carnitin eller acetylcarnitin

Country Status (11)

Country Link
US (1) US4599232A (da)
JP (1) JPS59186914A (da)
BE (1) BE898918A (da)
CH (1) CH655005A5 (da)
DE (1) DE3405581A1 (da)
DK (1) DK165167C (da)
FR (1) FR2543827B1 (da)
GB (1) GB2137088B (da)
IT (1) IT1170235B (da)
NL (1) NL192778C (da)
SE (1) SE457143B (da)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1209519B (it) * 1984-04-10 1989-08-30 Poli Ind Chimica Spa Composti ad attivita'cardiotrofica.
CH662505A5 (it) * 1985-04-30 1987-10-15 Seuref Ag Composizioni farmaceutiche ad azione protettiva vascolare.
CH670763A5 (da) * 1985-08-02 1989-07-14 Seuref Ag
CH666183A5 (it) * 1985-08-06 1988-07-15 Seuref Ag Composizione farmaceutica ad azione protettiva cardiaca e metabolica sul metabolismo energetico muscolare.
IT1184655B (it) * 1985-10-14 1987-10-28 Sigma Tau Ind Farmaceuti Imiego di acetil l-carnitina nel trattamento terapeutico degli stati di shock
SE8703321D0 (sv) * 1987-08-27 1987-08-27 Sockerbolaget Ab Kostforsterkning
JPH02188523A (ja) * 1989-01-13 1990-07-24 M S C:Kk 睡眠時無呼吸症治療薬
GB8907276D0 (en) * 1989-03-31 1989-05-17 Therapy Advisory Services Limi Health supplement
AT393954B (de) * 1990-02-28 1992-01-10 Bock Orthopaed Ind Verfahren und vorrichtung zur bestimmung von gebrauchseigenschaften eines prothesenschaftes
IT1254314B (it) * 1992-03-27 1995-09-14 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari.
AU666372B2 (en) * 1992-05-28 1996-02-08 Centre For Molecular Biology And Medicine Therapeutic compositions
DE4335454A1 (de) * 1993-10-19 1995-04-20 Schleicher Peter Geriatrikum
US5707971A (en) * 1995-06-07 1998-01-13 Life Resuscitation Technologies, Inc. Modulation of glycolytic ATP production
US6080788A (en) * 1997-03-27 2000-06-27 Sole; Michael J. Composition for improvement of cellular nutrition and mitochondrial energetics
DK0969744T3 (da) * 1997-03-27 2003-06-23 Khursheed N Jeejeebhoy Kosttilskud til forbedringer af celleenergetik
IT1291127B1 (it) * 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica
US5973004A (en) * 1997-04-04 1999-10-26 Howard; James R. L-carnitine, acetyl-L-carnitine, and pantothenic acid or ubiquinone, combined for prevention and treatment of syndromes related to ineffective energy metabolism
US5889055A (en) * 1997-04-04 1999-03-30 Howard; James R. L-carnitine and acetyl-L-carnitine combined for prevention and treatment of syndromes related to diseases of energy metabolism
US5916912A (en) * 1997-06-16 1999-06-29 The Regents Of The University Of California Dietary composition for enhancing metabolism and alleviating oxidative stress
US7371415B1 (en) 1998-04-03 2008-05-13 The Daily Wellness Company Method and composition for improving sexual fitness
AU3221599A (en) * 1998-04-03 1999-10-25 Daily Wellness Company, The Compositions comprising l-arginine, ginseng and gingko biloba for enhancing blood circulation
US20050196470A9 (en) * 1998-04-03 2005-09-08 Wuh Hank C Method and composition for enhancing sexual desire
IT1299266B1 (it) 1998-05-15 2000-02-29 Sigma Tau Ind Farmaceuti Inibitori reversibili della carnitina palmitoil trasferasi
US6616942B1 (en) 1999-03-29 2003-09-09 Soft Gel Technologies, Inc. Coenzyme Q10 formulation and process methodology for soft gel capsules manufacturing
WO2001021208A1 (en) 1999-09-23 2001-03-29 Juvenon Corporation Nutritional supplement for increased energy and stamina
US20070072927A1 (en) * 1999-09-23 2007-03-29 Vita Joseph A Nutritional supplement for increased energy and stamina
US6562869B1 (en) 1999-09-23 2003-05-13 Juvenon, Inc. Nutritional supplement for increased energy and stamina
EP1248609A4 (en) 1999-11-03 2007-08-01 Juvenon Inc METHOD FOR TREATING THE GOOD MEMORY TROUBLESHOOTING
US8753675B1 (en) * 2000-01-20 2014-06-17 Raj K. Chopra Reduced form of Coenzyme Q in high bioavailability stable dosage forms and related applications
US6740338B1 (en) 2000-01-20 2004-05-25 Raj K. Chopra Reduced form of Cenzyme Q in high bioavailability stable oral dosage form
WO2001058271A1 (en) * 2000-01-25 2001-08-16 Juvenon, Inc. Nutritional supplements for aged pets
DE10036798A1 (de) * 2000-07-28 2002-02-07 Beiersdorf Ag Mittel zur Behandlung der Haare und der Kopfhaut
US6441050B1 (en) 2000-08-29 2002-08-27 Raj K. Chopra Palatable oral coenzyme Q liquid
US6989164B2 (en) 2000-12-22 2006-01-24 The Daily Wellness Company Method and composition for improving male fertility health
US6497885B2 (en) 2000-12-22 2002-12-24 The Daily Wellness Company Method and composition for improving fertility health in female and male animals and humans
US6579866B2 (en) 2000-12-28 2003-06-17 Mccleary Larry Composition and method for modulating nutrient partitioning
US20060062864A1 (en) * 2000-12-28 2006-03-23 Mccleary Edward L Weight loss composition and method
US20040043013A1 (en) 2000-12-28 2004-03-04 Mccleary Edward Larry Metabolic uncoupling therapy
KR100685696B1 (ko) * 2001-05-10 2007-02-23 카네카 코포레이션 활성 성분으로 조효소 ｑ를 함유하는 경점막 투여용 조성물
CA2451163A1 (en) * 2001-06-28 2003-01-09 Takeda Chemical Industries, Ltd. Agent for preventing or treating organ functional disorders and order dysfunction
US8703209B2 (en) * 2003-06-17 2014-04-22 Edward Larry McCleary Composition and method for modulating hydrogen ion physiology
AU2004257756A1 (en) * 2003-07-10 2005-01-27 Carl A. Forest Foods, beverages, condiments, spices and salad dressings with specialized supplements
US20080089877A1 (en) * 2003-08-14 2008-04-17 Udell Ronald G Super Absorption Coenzyme Q10
US8124072B2 (en) 2003-09-29 2012-02-28 Soft Gel Technologies, Inc. Solubilized CoQ-10
US7169385B2 (en) * 2003-09-29 2007-01-30 Ronald G. Udell Solubilized CoQ-10 and carnitine
AU2004277951B2 (en) 2003-09-29 2010-11-11 Soft Gel Technologies, Inc. Solubilized CoQ-10
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
CN101022793B (zh) * 2004-06-29 2011-05-11 美国益力斯林公司 用以促进新陈代谢和降低活性氧水平的食品组合物
EP2564842A1 (en) * 2005-06-01 2013-03-06 Edison Pharmaceuticals, Inc. Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
US7887852B2 (en) * 2005-06-03 2011-02-15 Soft Gel Technologies, Inc. Soft gel capsules containing polymethoxylated flavones and palm oil tocotrienols
US20050249803A1 (en) * 2005-06-03 2005-11-10 Udell Ronald G Soft gel capsules containing polymethoxylated flavones and palm oil tocotrienols
LT1933821T (lt) * 2005-09-15 2020-11-10 Ptc Therapeutics, Inc. Šoninės grandinės variantai redoks aktyviųjų terapijos priemonių, skirtų mitochondrinių ligų ir kitokių būklių gydymui ir energijos biologinių žymenų moduliavimui
TW200735863A (en) * 2006-01-13 2007-10-01 Elixirin Corp Dietary compositions for enhancing metabolism and reducing reactive oxygen species
CA2635280C (en) 2006-02-22 2017-12-12 Edison Pharmaceuticals, Inc. Side chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
US20080020022A1 (en) * 2006-06-05 2008-01-24 Udell Ronald G Chewable co-enzyme q-10 capsule
ATE547743T1 (de) * 2007-03-14 2012-03-15 Fujifilm Corp Lichtempfindliche zusammensetzung und herstellungsverfahren für ein gehärtetes reliefmuster
US8343541B2 (en) 2007-03-15 2013-01-01 Soft Gel Technologies, Inc. Ubiquinol and alpha lipoic acid compositions
ES2306610B1 (es) * 2007-04-16 2009-09-11 Universidad De Sevilla Uso de la l-carnitina para el tratamiento de la hipertension arterial.
TW200916090A (en) * 2007-06-22 2009-04-16 Kaneka Corp Composition comprising coenzyme Q10
JP5343002B2 (ja) * 2007-06-22 2013-11-13 株式会社カネカ 生理活性物質含有組成物
US20110123505A1 (en) * 2007-08-22 2011-05-26 Kaneka Corporation Method of producing reduced coenzyme q10 and method of stabilizing the same
US8778410B2 (en) * 2008-02-19 2014-07-15 Earnest Medicine Co., Ltd. Oral or enteral composition useful for recovery of physical functions
LT3827815T (lt) 2008-09-10 2023-10-10 Ptc Therapeutics, Inc. Psichologinių raidos sutrikimų gydymas oksidacijos redukcijos atžvilgiu aktyviais vaistais
CA3008849A1 (en) 2015-12-17 2017-06-22 Bioelectron Technology Corporation Flouroalkyl, flouroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2903558C2 (de) * 1978-02-03 1994-09-01 Sigma Tau Ind Farmaceuti Verwendung von L-Carnitin
IT1206954B (it) * 1979-02-12 1989-05-17 Sigma Tau Ind Farmaceuti Agenti terapeutici a base di un acil derivato della carnitina per la cura di vasculopatie periferiche
US4346107A (en) * 1979-02-12 1982-08-24 Claudio Cavazza Pharmaceutical composition comprising acyl-carnitine for the treatment of impaired cerebral metabolism
IT1142934B (it) * 1981-11-06 1986-10-15 Sigma Tau Ind Farmaceuti Uso della carnitina e delle acilcarnitine inferiori nel trattamento terapeutico della patologia delle vene

Also Published As

Publication number Publication date
SE8400851D0 (sv) 1984-02-16
SE8400851L (sv) 1984-08-17
DK165167B (da) 1992-10-19
GB8403668D0 (en) 1984-03-14
BE898918A (nl) 1984-08-16
US4599232A (en) 1986-07-08
GB2137088A (en) 1984-10-03
NL192778C (nl) 1998-02-03
CH655005A5 (it) 1986-03-27
DK72284D0 (da) 1984-02-16
FR2543827B1 (fr) 1987-06-12
DE3405581A1 (de) 1984-10-18
JPS59186914A (ja) 1984-10-23
IT8323559A0 (it) 1983-10-31
DK165167C (da) 1993-03-01
IT1170235B (it) 1987-06-03
FR2543827A1 (fr) 1984-10-12
NL8400488A (nl) 1984-09-17
DE3405581C2 (da) 1992-10-22
SE457143B (sv) 1988-12-05
NL192778B (nl) 1997-10-01
GB2137088B (en) 1986-02-05
JPH027572B2 (da) 1990-02-19

Similar Documents

Publication Publication Date Title
DK72284A (da) Farmaceutisk middel med metabolisk og energetisk virkning til anvendelse i kardial- og vaskulaerterapi
DK162986D0 (da) Terapeutisk middel i enhedsdosisform
DK162472C (da) Laegemiddelform til afgivelse af et terapeutisk middel i periodontallommen og dens omgivelser
DK431384D0 (da) Enzymprodukter og deres anvendelse ved saceharificering
IT1094041B (it) Derivati d'acetammide impiegabili segnatamente in terapia,e procedimento per produrli
IT1153437B (it) Derivati 5-amminometil-ossazolidinici, procedimento per la loro preparazione, e loro applicazione in terapia
DK330082A (da) Motoriseret koerestol der kan drejes i alle retninger
DK453584D0 (da) Pyridinderivater til medicinsk anvendelse og farmaceutiske praeparater indeholdende pyridinderivater
DK424084A (da) Praeparat med foroeget collagenolytisk aktivitet og farmaceutiske midler indeholdende dette praeparat
DK358784D0 (da) Phenylquinolincarboxylsyrer, derivater og salte deraf, deres fremstilling og anvendelse i antitumormidler
DK515285A (da) Imidazoliumsalte med blodsukker-saenkende virkning og farmaceutiske midler indeholdende saadanne forbindelser
DK599986A (da) Terapeutisk middel i form af et hudplaster
DK432887D0 (da) Hudplejemidler med keratolytisk og antiinflammatorisk virkning
DK420986A (da) Dihydropyridin-2-hydroxyaminer, fremgangsmaade til deres fremstilling og deres anvendelse i laege-midler
DK131987A (da) Indretning til at forstyrre og narre stedbestemmelsesanlaeg for lyd i vandet
IT1153062B (it) Derivati benzilidenici, loro preparazione e loro applicazione in terapia
IT1142304B (it) Derivati dell'indano loro preparazione e loro applicazione in terapeutica
NO170941C (no) Polymerkompleks i vandig opploesning og anvendelse av dette
DK314681A (da) Farmaceutisk middel med antiflogistisk anti-pyretisk og analgetisk virkning
IT1176041B (it) Difenilazometine sostituite, loropreparazione e loro impiego in terapeutica
IT1176042B (it) Difenilazometine idrossilate, loropreparazione e loro impiego in terapeutica
DK499085D0 (da) Ergolinderivater og deres anvendelse i farmaceutiske midler
IT1190782B (it) Derivati diossazabiciclici,loro procedimento di preparazione e loro applicazione in terapia
JPS554301A (en) Drug in using for rheumatic therapy and its manufacture
IT1190669B (it) Derivati 1-spiro-isobenzofurnanici e 1-spiro-isobenzotiofenici,loro procedimento di preparazione e loro applicazione in terapia

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment
PUP Patent expired